nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine monophosphate—SRC—urinary bladder cancer	0.405	1	CbGaD
Adenosine monophosphate—Cytarabine—Gemcitabine—urinary bladder cancer	0.183	0.513	CrCrCtD
Adenosine monophosphate—Azacitidine—Gemcitabine—urinary bladder cancer	0.174	0.487	CrCrCtD
Adenosine monophosphate—AMPD1—prostate gland—urinary bladder cancer	0.0029	0.0298	CbGeAlD
Adenosine monophosphate—PRKAB2—prostate gland—urinary bladder cancer	0.0022	0.0226	CbGeAlD
Adenosine monophosphate—FBP1—prostate gland—urinary bladder cancer	0.00212	0.0218	CbGeAlD
Adenosine monophosphate—PYGL—prostate gland—urinary bladder cancer	0.0021	0.0216	CbGeAlD
Adenosine monophosphate—FBP1—seminal vesicle—urinary bladder cancer	0.0018	0.0184	CbGeAlD
Adenosine monophosphate—PYGL—seminal vesicle—urinary bladder cancer	0.00178	0.0182	CbGeAlD
Adenosine monophosphate—HINT1—prostate gland—urinary bladder cancer	0.00166	0.0171	CbGeAlD
Adenosine monophosphate—Cytarabine—POLB—urinary bladder cancer	0.00159	0.35	CrCbGaD
Adenosine monophosphate—PYGL—Azacitidine—Gemcitabine—urinary bladder cancer	0.00158	1	CbGdCrCtD
Adenosine monophosphate—PYGL—smooth muscle tissue—urinary bladder cancer	0.00149	0.0153	CbGeAlD
Adenosine monophosphate—PRKAB2—urethra—urinary bladder cancer	0.00147	0.0151	CbGeAlD
Adenosine monophosphate—FBP1—renal system—urinary bladder cancer	0.00145	0.0149	CbGeAlD
Adenosine monophosphate—AMPD1—vagina—urinary bladder cancer	0.00143	0.0147	CbGeAlD
Adenosine monophosphate—PRKAB1—prostate gland—urinary bladder cancer	0.00143	0.0146	CbGeAlD
Adenosine monophosphate—FBP1—urethra—urinary bladder cancer	0.00142	0.0146	CbGeAlD
Adenosine monophosphate—HINT1—seminal vesicle—urinary bladder cancer	0.00141	0.0145	CbGeAlD
Adenosine monophosphate—PYGL—urethra—urinary bladder cancer	0.00141	0.0144	CbGeAlD
Adenosine monophosphate—ACSS1—prostate gland—urinary bladder cancer	0.00138	0.0142	CbGeAlD
Adenosine monophosphate—PIM1—prostate gland—urinary bladder cancer	0.00134	0.0138	CbGeAlD
Adenosine monophosphate—ACSS2—prostate gland—urinary bladder cancer	0.00133	0.0136	CbGeAlD
Adenosine monophosphate—APRT—prostate gland—urinary bladder cancer	0.00133	0.0136	CbGeAlD
Adenosine monophosphate—ACSL1—prostate gland—urinary bladder cancer	0.00132	0.0135	CbGeAlD
Adenosine monophosphate—PRKAA1—prostate gland—urinary bladder cancer	0.00125	0.0128	CbGeAlD
Adenosine monophosphate—CREB1—prostate gland—urinary bladder cancer	0.00125	0.0128	CbGeAlD
Adenosine monophosphate—HINT1—epithelium—urinary bladder cancer	0.00122	0.0126	CbGeAlD
Adenosine monophosphate—PRKAB1—seminal vesicle—urinary bladder cancer	0.00121	0.0124	CbGeAlD
Adenosine monophosphate—HINT1—smooth muscle tissue—urinary bladder cancer	0.00118	0.0121	CbGeAlD
Adenosine monophosphate—ACSS1—seminal vesicle—urinary bladder cancer	0.00117	0.012	CbGeAlD
Adenosine monophosphate—PDE4D—prostate gland—urinary bladder cancer	0.00117	0.012	CbGeAlD
Adenosine monophosphate—PIM1—seminal vesicle—urinary bladder cancer	0.00114	0.0117	CbGeAlD
Adenosine monophosphate—HINT1—renal system—urinary bladder cancer	0.00113	0.0116	CbGeAlD
Adenosine monophosphate—ACSS2—seminal vesicle—urinary bladder cancer	0.00112	0.0115	CbGeAlD
Adenosine monophosphate—APRT—seminal vesicle—urinary bladder cancer	0.00112	0.0115	CbGeAlD
Adenosine monophosphate—HINT1—urethra—urinary bladder cancer	0.00111	0.0114	CbGeAlD
Adenosine monophosphate—ACSL1—seminal vesicle—urinary bladder cancer	0.00111	0.0114	CbGeAlD
Adenosine monophosphate—PRKAB2—vagina—urinary bladder cancer	0.00108	0.0111	CbGeAlD
Adenosine monophosphate—FBP1—vagina—urinary bladder cancer	0.00105	0.0108	CbGeAlD
Adenosine monophosphate—PYGL—vagina—urinary bladder cancer	0.00104	0.0106	CbGeAlD
Adenosine monophosphate—Clofarabine—RRM2—urinary bladder cancer	0.00102	0.223	CrCbGaD
Adenosine monophosphate—PRKAB1—renal system—urinary bladder cancer	0.000972	0.00998	CbGeAlD
Adenosine monophosphate—PRKAB1—urethra—urinary bladder cancer	0.000955	0.00981	CbGeAlD
Adenosine monophosphate—ACSS1—renal system—urinary bladder cancer	0.000943	0.00968	CbGeAlD
Adenosine monophosphate—APRT—smooth muscle tissue—urinary bladder cancer	0.000939	0.00964	CbGeAlD
Adenosine monophosphate—ACSS1—urethra—urinary bladder cancer	0.000926	0.00951	CbGeAlD
Adenosine monophosphate—AMPD1—lymph node—urinary bladder cancer	0.000925	0.0095	CbGeAlD
Adenosine monophosphate—PIM1—renal system—urinary bladder cancer	0.000916	0.00941	CbGeAlD
Adenosine monophosphate—CREB1—epithelium—urinary bladder cancer	0.000916	0.00941	CbGeAlD
Adenosine monophosphate—HINT1—female reproductive system—urinary bladder cancer	0.000908	0.00933	CbGeAlD
Adenosine monophosphate—ACSS2—renal system—urinary bladder cancer	0.000904	0.00928	CbGeAlD
Adenosine monophosphate—APRT—renal system—urinary bladder cancer	0.000904	0.00928	CbGeAlD
Adenosine monophosphate—PIM1—urethra—urinary bladder cancer	0.0009	0.00924	CbGeAlD
Adenosine monophosphate—ACSL1—renal system—urinary bladder cancer	0.000898	0.00922	CbGeAlD
Adenosine monophosphate—APRT—urethra—urinary bladder cancer	0.000888	0.00912	CbGeAlD
Adenosine monophosphate—ACSS2—urethra—urinary bladder cancer	0.000888	0.00912	CbGeAlD
Adenosine monophosphate—CREB1—smooth muscle tissue—urinary bladder cancer	0.000883	0.00907	CbGeAlD
Adenosine monophosphate—ACSL1—urethra—urinary bladder cancer	0.000882	0.00906	CbGeAlD
Adenosine monophosphate—SRC—prostate gland—urinary bladder cancer	0.000878	0.00902	CbGeAlD
Adenosine monophosphate—ADK—prostate gland—urinary bladder cancer	0.000866	0.0089	CbGeAlD
Adenosine monophosphate—Flavin adenine dinucleotide—POR—urinary bladder cancer	0.000863	0.19	CrCbGaD
Adenosine monophosphate—PRKAA1—renal system—urinary bladder cancer	0.00085	0.00873	CbGeAlD
Adenosine monophosphate—CREB1—renal system—urinary bladder cancer	0.00085	0.00873	CbGeAlD
Adenosine monophosphate—CREB1—urethra—urinary bladder cancer	0.000835	0.00857	CbGeAlD
Adenosine monophosphate—HINT1—vagina—urinary bladder cancer	0.000822	0.00844	CbGeAlD
Adenosine monophosphate—PRKAB1—female reproductive system—urinary bladder cancer	0.000779	0.008	CbGeAlD
Adenosine monophosphate—ACSS1—female reproductive system—urinary bladder cancer	0.000755	0.00775	CbGeAlD
Adenosine monophosphate—PIM1—female reproductive system—urinary bladder cancer	0.000734	0.00754	CbGeAlD
Adenosine monophosphate—ADK—seminal vesicle—urinary bladder cancer	0.000733	0.00752	CbGeAlD
Adenosine monophosphate—APRT—female reproductive system—urinary bladder cancer	0.000724	0.00743	CbGeAlD
Adenosine monophosphate—ACSS2—female reproductive system—urinary bladder cancer	0.000724	0.00743	CbGeAlD
Adenosine monophosphate—ACSL1—female reproductive system—urinary bladder cancer	0.000719	0.00738	CbGeAlD
Adenosine monophosphate—PRKAB1—vagina—urinary bladder cancer	0.000704	0.00723	CbGeAlD
Adenosine monophosphate—PRKAB2—lymph node—urinary bladder cancer	0.000701	0.0072	CbGeAlD
Adenosine monophosphate—ACSS1—vagina—urinary bladder cancer	0.000683	0.00701	CbGeAlD
Adenosine monophosphate—PRKAA1—female reproductive system—urinary bladder cancer	0.000681	0.00699	CbGeAlD
Adenosine monophosphate—CREB1—female reproductive system—urinary bladder cancer	0.000681	0.00699	CbGeAlD
Adenosine monophosphate—FBP1—lymph node—urinary bladder cancer	0.000678	0.00696	CbGeAlD
Adenosine monophosphate—PYGL—lymph node—urinary bladder cancer	0.000671	0.00689	CbGeAlD
Adenosine monophosphate—PIM1—vagina—urinary bladder cancer	0.000664	0.00682	CbGeAlD
Adenosine monophosphate—ADCY1—lymph node—urinary bladder cancer	0.000657	0.00675	CbGeAlD
Adenosine monophosphate—APRT—vagina—urinary bladder cancer	0.000655	0.00672	CbGeAlD
Adenosine monophosphate—ACSS2—vagina—urinary bladder cancer	0.000655	0.00672	CbGeAlD
Adenosine monophosphate—ACSL1—vagina—urinary bladder cancer	0.00065	0.00668	CbGeAlD
Adenosine monophosphate—SRC—epithelium—urinary bladder cancer	0.000645	0.00663	CbGeAlD
Adenosine monophosphate—SRC—smooth muscle tissue—urinary bladder cancer	0.000622	0.00639	CbGeAlD
Adenosine monophosphate—PDE4B—prostate gland—urinary bladder cancer	0.000616	0.00633	CbGeAlD
Adenosine monophosphate—CREB1—vagina—urinary bladder cancer	0.000615	0.00632	CbGeAlD
Adenosine monophosphate—ADK—smooth muscle tissue—urinary bladder cancer	0.000613	0.0063	CbGeAlD
Adenosine monophosphate—SRC—renal system—urinary bladder cancer	0.000599	0.00615	CbGeAlD
Adenosine monophosphate—ADK—renal system—urinary bladder cancer	0.00059	0.00606	CbGeAlD
Adenosine monophosphate—Cladribine—RRM2—urinary bladder cancer	0.000583	0.128	CrCbGaD
Adenosine monophosphate—ADK—urethra—urinary bladder cancer	0.00058	0.00596	CbGeAlD
Adenosine monophosphate—HINT1—lymph node—urinary bladder cancer	0.000531	0.00546	CbGeAlD
Adenosine monophosphate—Flavin adenine dinucleotide—NQO1—urinary bladder cancer	0.000496	0.109	CrCbGaD
Adenosine monophosphate—SRC—female reproductive system—urinary bladder cancer	0.000479	0.00492	CbGeAlD
Adenosine monophosphate—ADK—female reproductive system—urinary bladder cancer	0.000473	0.00486	CbGeAlD
Adenosine monophosphate—PRKAB1—lymph node—urinary bladder cancer	0.000455	0.00468	CbGeAlD
Adenosine monophosphate—ACSS1—lymph node—urinary bladder cancer	0.000442	0.00454	CbGeAlD
Adenosine monophosphate—PIM1—lymph node—urinary bladder cancer	0.000429	0.00441	CbGeAlD
Adenosine monophosphate—ADK—vagina—urinary bladder cancer	0.000428	0.00439	CbGeAlD
Adenosine monophosphate—ACSS2—lymph node—urinary bladder cancer	0.000423	0.00435	CbGeAlD
Adenosine monophosphate—APRT—lymph node—urinary bladder cancer	0.000423	0.00435	CbGeAlD
Adenosine monophosphate—ACSL1—lymph node—urinary bladder cancer	0.000421	0.00432	CbGeAlD
Adenosine monophosphate—PDE4B—urethra—urinary bladder cancer	0.000412	0.00424	CbGeAlD
Adenosine monophosphate—PRKAA1—lymph node—urinary bladder cancer	0.000398	0.00409	CbGeAlD
Adenosine monophosphate—CREB1—lymph node—urinary bladder cancer	0.000398	0.00409	CbGeAlD
Adenosine monophosphate—PDE4D—lymph node—urinary bladder cancer	0.000373	0.00383	CbGeAlD
Adenosine monophosphate—PDE4B—female reproductive system—urinary bladder cancer	0.000336	0.00345	CbGeAlD
Adenosine monophosphate—PDE4B—vagina—urinary bladder cancer	0.000304	0.00312	CbGeAlD
Adenosine monophosphate—SRC—lymph node—urinary bladder cancer	0.00028	0.00288	CbGeAlD
Adenosine monophosphate—ADK—lymph node—urinary bladder cancer	0.000277	0.00284	CbGeAlD
Adenosine monophosphate—PDE4B—lymph node—urinary bladder cancer	0.000197	0.00202	CbGeAlD
Adenosine monophosphate—PRKAB1—Signaling Pathways—IL2—urinary bladder cancer	7.03e-06	5.23e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—CREBBP—urinary bladder cancer	7.02e-06	5.22e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—IGF1—urinary bladder cancer	6.93e-06	5.16e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—FGFR3—urinary bladder cancer	6.92e-06	5.16e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by NGF—KRAS—urinary bladder cancer	6.91e-06	5.15e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—CDKN1A—urinary bladder cancer	6.86e-06	5.11e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—CDH1—urinary bladder cancer	6.85e-06	5.1e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—CCND1—urinary bladder cancer	6.85e-06	5.1e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—PTEN—urinary bladder cancer	6.84e-06	5.1e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Adaptive Immune System—EGFR—urinary bladder cancer	6.84e-06	5.09e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—ERBB2—urinary bladder cancer	6.81e-06	5.08e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—S100B—urinary bladder cancer	6.76e-06	5.04e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Innate Immune System—KRAS—urinary bladder cancer	6.73e-06	5.01e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—ESR1—urinary bladder cancer	6.73e-06	5.01e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—NCOR1—urinary bladder cancer	6.71e-06	5e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—CREBBP—urinary bladder cancer	6.69e-06	4.98e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—MYC—urinary bladder cancer	6.68e-06	4.97e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—MMP9—urinary bladder cancer	6.65e-06	4.95e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—CDKN1A—urinary bladder cancer	6.63e-06	4.93e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Axon guidance—EGFR—urinary bladder cancer	6.62e-06	4.93e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—PTEN—urinary bladder cancer	6.61e-06	4.92e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—IGF1—urinary bladder cancer	6.61e-06	4.92e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—CREBBP—urinary bladder cancer	6.6e-06	4.91e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling by GPCR—EGFR—urinary bladder cancer	6.58e-06	4.9e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—EGFR—urinary bladder cancer	6.53e-06	4.87e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—EP300—urinary bladder cancer	6.53e-06	4.86e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Developmental Biology—HRAS—urinary bladder cancer	6.48e-06	4.82e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Adaptive Immune System—KRAS—urinary bladder cancer	6.46e-06	4.81e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—SRC—urinary bladder cancer	6.35e-06	4.73e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—RHOA—urinary bladder cancer	6.35e-06	4.73e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—CDKN1A—urinary bladder cancer	6.33e-06	4.72e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—PTEN—urinary bladder cancer	6.32e-06	4.71e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—EP300—urinary bladder cancer	6.3e-06	4.7e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Axon guidance—KRAS—urinary bladder cancer	6.25e-06	4.66e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling by GPCR—KRAS—urinary bladder cancer	6.21e-06	4.63e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—CXCL8—urinary bladder cancer	6.21e-06	4.63e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—CREBBP—urinary bladder cancer	6.2e-06	4.61e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—KRAS—urinary bladder cancer	6.17e-06	4.6e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—SRC—urinary bladder cancer	6.13e-06	4.57e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—IGF1—urinary bladder cancer	6.12e-06	4.56e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—EGFR—urinary bladder cancer	6.09e-06	4.53e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—PTGS2—urinary bladder cancer	6.07e-06	4.52e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—IL2—urinary bladder cancer	6.06e-06	4.51e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—RHOA—urinary bladder cancer	6.05e-06	4.51e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—RBX1—urinary bladder cancer	6.03e-06	4.49e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—EP300—urinary bladder cancer	6.03e-06	4.49e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—ERBB2—urinary bladder cancer	6.02e-06	4.48e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—ERBB2—urinary bladder cancer	5.98e-06	4.46e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—RHOA—urinary bladder cancer	5.97e-06	4.45e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—IL2—urinary bladder cancer	5.94e-06	4.42e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—TERT—urinary bladder cancer	5.91e-06	4.4e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CREBBP—urinary bladder cancer	5.89e-06	4.39e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—ERBB2—urinary bladder cancer	5.88e-06	4.38e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by NGF—HRAS—urinary bladder cancer	5.87e-06	4.37e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—SRC—urinary bladder cancer	5.86e-06	4.36e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—MMP9—urinary bladder cancer	5.85e-06	4.35e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—IGF1—urinary bladder cancer	5.82e-06	4.33e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—EGFR—urinary bladder cancer	5.79e-06	4.31e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—ERBB2—urinary bladder cancer	5.78e-06	4.3e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—KRAS—urinary bladder cancer	5.75e-06	4.28e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Innate Immune System—HRAS—urinary bladder cancer	5.72e-06	4.26e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TSC1—urinary bladder cancer	5.67e-06	4.22e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—NCOR1—urinary bladder cancer	5.61e-06	4.18e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—RHOA—urinary bladder cancer	5.61e-06	4.17e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—ERBB2—urinary bladder cancer	5.6e-06	4.17e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—CXCL8—urinary bladder cancer	5.57e-06	4.15e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—EGFR—urinary bladder cancer	5.56e-06	4.14e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—EP300—urinary bladder cancer	5.54e-06	4.13e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—ERBB2—urinary bladder cancer	5.53e-06	4.11e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—MYC—urinary bladder cancer	5.49e-06	4.09e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Adaptive Immune System—HRAS—urinary bladder cancer	5.49e-06	4.09e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—TP53—urinary bladder cancer	5.48e-06	4.08e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—KRAS—urinary bladder cancer	5.47e-06	4.07e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—EP300—urinary bladder cancer	5.44e-06	4.05e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—FGFR3—urinary bladder cancer	5.43e-06	4.04e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—IL2—urinary bladder cancer	5.42e-06	4.04e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—PTGS2—urinary bladder cancer	5.4e-06	4.02e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—JAG1—urinary bladder cancer	5.4e-06	4.02e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—EGFR—urinary bladder cancer	5.37e-06	4e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—RHOA—urinary bladder cancer	5.33e-06	3.97e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—IL2—urinary bladder cancer	5.32e-06	3.97e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Axon guidance—HRAS—urinary bladder cancer	5.32e-06	3.96e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—CXCL8—urinary bladder cancer	5.32e-06	3.96e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—PTEN—urinary bladder cancer	5.29e-06	3.94e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling by GPCR—HRAS—urinary bladder cancer	5.28e-06	3.93e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—ERCC2—urinary bladder cancer	5.28e-06	3.93e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—ESR1—urinary bladder cancer	5.27e-06	3.93e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—KRAS—urinary bladder cancer	5.26e-06	3.91e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—MYC—urinary bladder cancer	5.25e-06	3.91e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—HRAS—urinary bladder cancer	5.25e-06	3.91e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—CCND1—urinary bladder cancer	5.19e-06	3.87e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—ERBB2—urinary bladder cancer	5.19e-06	3.86e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—CDKN1A—urinary bladder cancer	5.14e-06	3.83e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—EGFR—urinary bladder cancer	5.14e-06	3.83e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—PTEN—urinary bladder cancer	5.13e-06	3.82e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—CDKN1A—urinary bladder cancer	5.11e-06	3.81e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—PTEN—urinary bladder cancer	5.1e-06	3.8e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—IL2—urinary bladder cancer	5.08e-06	3.78e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—KRAS—urinary bladder cancer	5.08e-06	3.78e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—EP300—urinary bladder cancer	5.05e-06	3.76e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—MMP9—urinary bladder cancer	5.04e-06	3.75e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.02e-06	3.74e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—PTEN—urinary bladder cancer	5.01e-06	3.73e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MTHFR—urinary bladder cancer	4.96e-06	3.69e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—CCND1—urinary bladder cancer	4.95e-06	3.69e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—TERT—urinary bladder cancer	4.95e-06	3.68e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—CDKN1A—urinary bladder cancer	4.94e-06	3.68e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—ERBB2—urinary bladder cancer	4.94e-06	3.68e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—PTEN—urinary bladder cancer	4.93e-06	3.67e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—CXCL8—urinary bladder cancer	4.92e-06	3.67e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—FGFR3—urinary bladder cancer	4.92e-06	3.66e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—EP300—urinary bladder cancer	4.89e-06	3.65e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—HRAS—urinary bladder cancer	4.89e-06	3.64e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—EP300—urinary bladder cancer	4.87e-06	3.62e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—KRAS—urinary bladder cancer	4.85e-06	3.61e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—MMP9—urinary bladder cancer	4.81e-06	3.58e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—CDKN1A—urinary bladder cancer	4.79e-06	3.57e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—PTEN—urinary bladder cancer	4.78e-06	3.56e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—EP300—urinary bladder cancer	4.78e-06	3.56e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—SRC—urinary bladder cancer	4.73e-06	3.52e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—EGFR—urinary bladder cancer	4.72e-06	3.52e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—CDKN1A—urinary bladder cancer	4.72e-06	3.52e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—PTEN—urinary bladder cancer	4.71e-06	3.51e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—IL2—urinary bladder cancer	4.7e-06	3.5e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CXCL8—urinary bladder cancer	4.68e-06	3.49e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—HRAS—urinary bladder cancer	4.65e-06	3.46e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—SRC—urinary bladder cancer	4.65e-06	3.46e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CREBBP—urinary bladder cancer	4.62e-06	3.44e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—CCND1—urinary bladder cancer	4.58e-06	3.41e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IGF1—urinary bladder cancer	4.56e-06	3.4e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—EP300—urinary bladder cancer	4.56e-06	3.39e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—FGFR3—urinary bladder cancer	4.54e-06	3.38e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—EGFR—urinary bladder cancer	4.54e-06	3.38e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—TP53—urinary bladder cancer	4.51e-06	3.36e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—TNF—urinary bladder cancer	4.5e-06	3.35e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—EP300—urinary bladder cancer	4.49e-06	3.35e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—IL2—urinary bladder cancer	4.47e-06	3.33e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—HRAS—urinary bladder cancer	4.47e-06	3.33e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—KRAS—urinary bladder cancer	4.46e-06	3.32e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—MMP9—urinary bladder cancer	4.45e-06	3.32e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—CDKN1A—urinary bladder cancer	4.44e-06	3.3e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—SRC—urinary bladder cancer	4.43e-06	3.3e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—PTEN—urinary bladder cancer	4.43e-06	3.3e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—KRAS—urinary bladder cancer	4.38e-06	3.26e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—S100B—urinary bladder cancer	4.37e-06	3.26e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—SRC—urinary bladder cancer	4.37e-06	3.25e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CCND1—urinary bladder cancer	4.36e-06	3.25e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—HRAS—urinary bladder cancer	4.31e-06	3.21e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—KRAS—urinary bladder cancer	4.29e-06	3.19e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—MMP9—urinary bladder cancer	4.23e-06	3.15e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—EP300—urinary bladder cancer	4.22e-06	3.14e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CDKN1A—urinary bladder cancer	4.22e-06	3.14e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—PTEN—urinary bladder cancer	4.21e-06	3.13e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CREBBP—urinary bladder cancer	4.19e-06	3.12e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—RHOA—urinary bladder cancer	4.18e-06	3.11e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—EGFR—urinary bladder cancer	4.17e-06	3.11e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—MYC—urinary bladder cancer	4.16e-06	3.1e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CDH1—urinary bladder cancer	4.15e-06	3.09e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—EGFR—urinary bladder cancer	4.15e-06	3.09e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—HRAS—urinary bladder cancer	4.12e-06	3.07e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—SRC—urinary bladder cancer	4.1e-06	3.06e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—EGFR—urinary bladder cancer	4.07e-06	3.03e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—EP300—urinary bladder cancer	4.01e-06	2.99e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—EGFR—urinary bladder cancer	4.01e-06	2.98e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—MYC—urinary bladder cancer	3.97e-06	2.96e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—KRAS—urinary bladder cancer	3.94e-06	2.94e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—NCOR1—urinary bladder cancer	3.93e-06	2.93e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—KRAS—urinary bladder cancer	3.92e-06	2.92e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—MYC—urinary bladder cancer	3.92e-06	2.92e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—SRC—urinary bladder cancer	3.9e-06	2.91e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—TP53—urinary bladder cancer	3.89e-06	2.9e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—EGFR—urinary bladder cancer	3.88e-06	2.89e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—ERBB2—urinary bladder cancer	3.87e-06	2.88e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CREBBP—urinary bladder cancer	3.86e-06	2.88e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—KRAS—urinary bladder cancer	3.85e-06	2.86e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—EGFR—urinary bladder cancer	3.83e-06	2.85e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—HRAS—urinary bladder cancer	3.79e-06	2.82e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—KRAS—urinary bladder cancer	3.78e-06	2.82e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—HRAS—urinary bladder cancer	3.72e-06	2.77e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—MYC—urinary bladder cancer	3.68e-06	2.74e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—KRAS—urinary bladder cancer	3.67e-06	2.73e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CXCL8—urinary bladder cancer	3.67e-06	2.73e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—HRAS—urinary bladder cancer	3.65e-06	2.71e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—KRAS—urinary bladder cancer	3.62e-06	2.69e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—EGFR—urinary bladder cancer	3.6e-06	2.68e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IL2—urinary bladder cancer	3.51e-06	2.61e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—ERBB2—urinary bladder cancer	3.51e-06	2.61e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—MYC—urinary bladder cancer	3.5e-06	2.61e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—RHOA—urinary bladder cancer	3.5e-06	2.6e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TERT—urinary bladder cancer	3.46e-06	2.58e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—EGFR—urinary bladder cancer	3.42e-06	2.55e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—TP53—urinary bladder cancer	3.42e-06	2.55e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CCND1—urinary bladder cancer	3.42e-06	2.55e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—KRAS—urinary bladder cancer	3.4e-06	2.53e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—HRAS—urinary bladder cancer	3.35e-06	2.49e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—HRAS—urinary bladder cancer	3.33e-06	2.48e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MMP9—urinary bladder cancer	3.32e-06	2.47e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CDKN1A—urinary bladder cancer	3.31e-06	2.46e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—PTEN—urinary bladder cancer	3.3e-06	2.46e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—HRAS—urinary bladder cancer	3.27e-06	2.44e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—TP53—urinary bladder cancer	3.26e-06	2.43e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—ERBB2—urinary bladder cancer	3.24e-06	2.41e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—KRAS—urinary bladder cancer	3.23e-06	2.41e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—HRAS—urinary bladder cancer	3.22e-06	2.4e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—FGFR3—urinary bladder cancer	3.18e-06	2.37e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL2—urinary bladder cancer	3.18e-06	2.37e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PTGS2—urinary bladder cancer	3.16e-06	2.36e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—EP300—urinary bladder cancer	3.15e-06	2.34e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—HRAS—urinary bladder cancer	3.12e-06	2.32e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—ESR1—urinary bladder cancer	3.09e-06	2.3e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—HRAS—urinary bladder cancer	3.08e-06	2.29e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—SRC—urinary bladder cancer	3.06e-06	2.28e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—TP53—urinary bladder cancer	3.02e-06	2.25e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CDKN1A—urinary bladder cancer	3e-06	2.23e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—PTEN—urinary bladder cancer	2.99e-06	2.23e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—HRAS—urinary bladder cancer	2.89e-06	2.15e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—TP53—urinary bladder cancer	2.87e-06	2.14e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—EP300—urinary bladder cancer	2.85e-06	2.12e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CDKN1A—urinary bladder cancer	2.77e-06	2.06e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PTEN—urinary bladder cancer	2.76e-06	2.06e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—HRAS—urinary bladder cancer	2.75e-06	2.05e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MYC—urinary bladder cancer	2.74e-06	2.04e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CREBBP—urinary bladder cancer	2.71e-06	2.02e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—EGFR—urinary bladder cancer	2.68e-06	2e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IGF1—urinary bladder cancer	2.67e-06	1.99e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—EP300—urinary bladder cancer	2.63e-06	1.96e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—KRAS—urinary bladder cancer	2.53e-06	1.89e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—RHOA—urinary bladder cancer	2.45e-06	1.82e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—EGFR—urinary bladder cancer	2.43e-06	1.81e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—KRAS—urinary bladder cancer	2.3e-06	1.71e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MYC—urinary bladder cancer	2.29e-06	1.71e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—ERBB2—urinary bladder cancer	2.27e-06	1.69e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—TP53—urinary bladder cancer	2.25e-06	1.68e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—EGFR—urinary bladder cancer	2.24e-06	1.67e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—HRAS—urinary bladder cancer	2.15e-06	1.6e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CXCL8—urinary bladder cancer	2.15e-06	1.6e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—KRAS—urinary bladder cancer	2.12e-06	1.58e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IL2—urinary bladder cancer	2.05e-06	1.53e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CCND1—urinary bladder cancer	2e-06	1.49e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—HRAS—urinary bladder cancer	1.95e-06	1.45e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MMP9—urinary bladder cancer	1.94e-06	1.45e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CDKN1A—urinary bladder cancer	1.94e-06	1.44e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PTEN—urinary bladder cancer	1.93e-06	1.44e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—EP300—urinary bladder cancer	1.84e-06	1.37e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—HRAS—urinary bladder cancer	1.8e-06	1.34e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MYC—urinary bladder cancer	1.61e-06	1.2e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—EGFR—urinary bladder cancer	1.57e-06	1.17e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—KRAS—urinary bladder cancer	1.48e-06	1.11e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TP53—urinary bladder cancer	1.32e-06	9.82e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—HRAS—urinary bladder cancer	1.26e-06	9.39e-06	CbGpPWpGaD
